Future Science and Newlands Press, imprints of Future Science Group, focus on applied science and intellectual property issues in R&D. Our journals and eBooks take readers through the pharmaceutical R&D pipeline – from drug discovery, delivery, pharmacokinetics and analytical techniques, through to commentary and analysis on patent and IP issues. Our flagship gold open access journal, Future Science OA, also embraces the importance of publishing all good-quality research, and covers all areas of biotechnology and medicine, as well as topics in biological, life and physical sciences that are of relevance to human health.